UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
M M0 M1 M2 M4 M5 M7 M8 M9 MA MB MC MD ME MF MG MH MI MK ML MM MN MO MP MR MS MT MU MV MY
MYA MYB MYC MYD MYE MYH MYI MYL MYO MYP MYR MYT MYX
selected terms: 54 page 1 of 1

1. Myectomy
(UMLS (NCI) C0185279) =Therapeutic or Preventive Procedure
28. Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells
(UMLS (NCI) C1334846) Myeloblasts Under 10% of Bone Marrow Nucleated Cells;
=Laboratory or Test Result
2. myelencephalon
[The most posterior portion of the hindbrain from which MEDULLA OBLONGATA is derived. ( MSH )] (UMLS (CSP) C1959627) =Body Part, Organ, or Organ Component
29. Myeloblasts Under 2 Percent of Peripheral Blood White Cells
(UMLS (NCI) C1334850) Myeloblasts Under 2% of Peripheral Blood White Cells =Laboratory or Test Result
3. myelin
[fatty, axon-enwrapping sheath that serves to speed up neural conduction, formed by concentric layers of Schwann's cell (peripheral) or oligodendrocyte (CNS) membranes; loss or damage leads to severe loss of neural function, as in multiple sclerosis. ( CSP )] (UMLS (NCI) C0026969) =Tissue =Body System, Neurologic;
=Node of Ranvier;
myelination;
30. Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells
(UMLS (NCI) C1334848) Myeloblasts Under 20% of Bone Marrow Nucleated Cells =Laboratory or Test Result
4. Myelin
[The lipid-rich sheath surrounding AXONS in both the central and peripheral nervous systems. The myelin sheath is an electrical insulator and allows faster and more energetically efficient conduction of impulses. The sheath is formed by the cell membranes of glial cells (SCHWANN CELLS in the peripheral and OLIGODENDROGLIA in the central nervous system). Deterioration of the sheath in DEMYELINATING DISEASES is a serious clinical problem. ( MSH )] (UMLS (NCI) C0026973) =Cell Component
31. Myeloblasts Under 20 Percent of Peripheral Blood White Cells
(UMLS (NCI) C1334849) Myeloblasts Under 20% of Peripheral Blood White Cells =Laboratory or Test Result
5. myelin basic protein
[positively charged myelin protein believed to be the autoantigen in multiple sclerosis and its animal model, EAE. ( CSP )] (UMLS (CSP) C0014063) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine =nerve/myelin protein;
32. Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells
(UMLS (NCI) C1334851) Myeloblasts Under 5% of Bone Marrow Nucleated Cells =Laboratory or Test Result
6. myelin degeneration
[ ] (UMLS (CSP) C0333456) =Pathologic Function
33. Myeloblasts Under 5 Percent of Peripheral Blood White Cells
(UMLS (NCI) C1334852) Myeloblasts Under 5% of Peripheral Blood White Cells =Laboratory or Test Result
7. myelin protein
[Proteins found in the myelin sheath. The major proteins of central nervous system myelin include: MYELIN PROTEOLIPID PROTEIN; MYELIN BASIC PROTEINS; and MYELIN-ASSOCIATED GLYCOPROTEIN. The major proteins of peripheral nervous system myelin include: MYELIN BASIC PROTEINS (myelin P1 protein and MYELIN P2 PROTEIN); MYELIN P0 PROTEIN; and MYELIN-ASSOCIATED GLYCOPROTEIN. ( MSH )] (UMLS (CSP) C0026972) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
34. Myelobromol
(UMLS (NCI) C0700014) =Carbohydrate; Pharmacologic Substance ;
8. myelin proteolipid
[family of fatty acylated, extremely hydrophobic membrane proteins that serve to glue the intracellular faces of myelin lamellae in tight apposition; accounts for more than half of total myelin protein. ( CSP )] (UMLS (CSP) C0060617) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine =proteolipid;
nerve/myelin protein
35. myelocyte
[precursor in the granulocytic series; in this stage, differentiation into specific cytoplasmic granules has begun. ( CSP )] (UMLS (CSP) C0369715) =Cell ;
=Granulocyte;
9. Myelinated Nerve Fiber
[Axons of neurons encased in a lipoproteinaceous material called myelin. (MeSH) ( NCI )] (UMLS (NCI) C0027750) =Cell Component ;
36. Myelocytic Leukemia in Remission
[Granulocytic leukemia, remission. 1. Abatement or lessening in severity of the symptoms of a disease. 2. The period during which such abatement occurs. ( NCI )] (UMLS (NCI) C0686593) =Neoplastic Process
10. myelination
[forming of the myelin sheath, the cylindrical covering that insulates the axons of some neurons; formed from the plasma membrane of Schwann cells or oligodendrocytes. ( CSP )] (UMLS (CSP) C0596991) =Cell Function =myelin;
37. myelodysplastic anemia
[ ] (UMLS (CSP) C0598338) =Disease or Syndrome
11. myelinopathy
[disease or destruction of myelin, the myelin sheath, or the white matter of the brain. ( CSP )] (UMLS (CSP) C0596992) =Disease or Syndrome =Central Nervous System Disease;
=autoimmune encephalomyelitis;
cerebrotendinous xanthomatosis;
Marchiafava Bignami disease;
telencephalic leukoencephalopathy;
viral myelinopathy;
38. Myelodysplastic syndrome with 5q deletion
[ ] (UMLS (ICD9CM) C1719311) MYELODYSPLS SYN W 5Q DEL =Disease or Syndrome
12. myelitis
[Inflammation of the spinal cord. Relatively common etiologies include infections; AUTOIMMUNE DISEASES; SPINAL CORD; and ischemia (see also SPINAL CORD VASCULAR DISEASES). Clinical features generally include weakness, sensory loss, localized pain, incontinence, and other signs of autonomic dysfunction. ( MSH )] (UMLS (CSP) C0026975) =Disease or Syndrome =myelopathy;
Central Nervous System Viral Diseases =Myelitis, Transverse;
Paraparesis, Tropical Spastic;
Acute Poliomyelitis
39. myelogenous
[(mye-eh-LAH-jen-us) Produced by, or originating in, the bone marrow. ( NCI )] (UMLS (NCI) C0439677) =Qualitative Concept
13. MYELITIS CAUSE NEC
[ ] (UMLS (ICD9CM) C1719367) Other causes of myelitis =Disease or Syndrome ;
40. Myelogram
(UMLS (HL7) C1548886) =Health Care Activity =Consent Type;
14. MYELITIS D/T OTH INFECT
[ ] (UMLS (ICD9CM) C1719351) Other myelitis due to infection classified elsewhere =Disease or Syndrome
41. Myeloid Cell
[Cells which include the monocytes and the granulocytes. (MeSH) ( NCI )] (UMLS (NCI) C0887899) Myeloid Cells =Cell ;
15. Myelitis following immunization procedures
[ ] (UMLS (ICD9CM) C1719356) MYELITIS FOLLWG IMMUNE =Disease or Syndrome ;
42. Myeloid sarcoma without mention of remission
(UMLS (ICD9CM) C0153891) =Neoplastic Process
16. Myelitis in viral diseases classified elsewhere
[ ] (UMLS (ICD9CM) C1719347) MYELITIS-OTH VIRAL DIS =Disease or Syndrome
43. Myeloleukon
(UMLS (NCI) C0728928) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
17. Myeloablative Agonist
[Agents that destroy bone marrow activity. They are used to prepare patients for BONE MARROW TRANSPLANTATION or STEM CELL TRANSPLANTATION. ( MSH )] (UMLS (NCI) C0524867) =Pharmacologic Substance ;
44. myeloma and spleen cell hybrid
[ ] (UMLS (CSP) C0598625) =Cell ;
18. Myeloblast
[An immature cell that represents the first stage in the granulocytic series of hematopoiesis. It is found in bone marrow and differentiates into a promyelocyte. Its nucleus is composed of very fine, evenly distributed chromatin with 2-5 nucleoli. The cytoplasm is basophilic and non-granular. ( NCI )] (UMLS (NCI) C0229633) =Cell ;
45. myeloma globulin
[abnormal globulins with unusual thermosolubility characteristics that are found in the urine of patients with multiple myeloma. ( CSP )] (UMLS (CSP) C0178753) =Amino Acid, Peptide, or Protein; Biologically Active Substance =globulin;
19. Myeloblasts 10-19 Percent of Bone Marrow Nucleated Cells
(UMLS (NCI) C1334838) Myeloblasts Between 10 and 19 Percent of Bone Marrow Nucleated Cells;
Myeloblasts Between 10 and 19% of Bone Marrow Nucleated Cells =Laboratory or Test Result ;
46. MYELOMENINGOCEL REPAIR
[ ] (UMLS (ICD9CM) C0196477) =Therapeutic or Preventive Procedure
20. Myeloblasts 10-19 Percent of Peripheral Blood White Cells
(UMLS (NCI) C1334839) Myeloblasts Between 10 and 19% of Peripheral Blood White Cells;
=Laboratory or Test Result
47. myelopathy
[pathologic conditions which feature spinal cord damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. ( CSP )] (UMLS (CSP) C0037928) =Disease or Syndrome ;
=Central Nervous System Disease;
=amyotonia congenita;
ALS;
Injury, spinal cord;
PROG MUSCULAR ATROPHY;
ALS;
Muscular Atrophy, Spinal;
myelitis;
Injury, spinal cord;
Neoplasm of Spinal Cord;
Spinocerebellar Degenerations;
syringomyelia;
Tabes dorsalis;
stiff man syndrome;
Epidural Abscess;
Spinal Cord Vascular Diseases
21. Myeloblasts 20 Percent or More of Bone Marrow Non-Erythroid Cells
(UMLS (NCI) C1334840) Myeloblasts 20% or More of Bone Marrow Non-Erythroid Cells;
=Laboratory or Test Result
48. MYELOPATHY IN OTH DIS
(UMLS (ICD9CM) C0154687) =Disease or Syndrome ;
22. Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells
(UMLS (NCI) C1334841) Myeloblasts 20% or More of Bone Marrow Nucleated Cells;
=Laboratory or Test Result
49. MYELOPATHY NEC
[ ] (UMLS (ICD9CM) C1961841) Other myelopathy;
=Disease or Syndrome ;
23. Myeloblasts 20 Percent or More of Peripheral Blood White Cells
(UMLS (NCI) C1334842) Myeloblasts 20% or More of Peripheral Blood White Cells;
=Laboratory or Test Result
50. myeloperoxidase
[A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. ( MSH )] (UMLS (CSP) C0027021) =Amino Acid, Peptide, or Protein; Enzyme ;
=peroxidase;
24. Myeloblasts 5-19 Percent of Bone Marrow Nucleated Cells
(UMLS (NCI) C1334843) Myeloblasts 5-19% of Bone Marrow Nucleated Cells;
=Laboratory or Test Result
51. MYELOPHTHISIS
(UMLS (ICD9CM) C0302112) =Cell or Molecular Dysfunction ;
25. Myeloblasts 5-19 Percent of Peripheral Blood White Cells
(UMLS (NCI) C1334844) Myeloblasts 5-19% of Peripheral Blood White Cells;
=Laboratory or Test Result
52. Myelopoiesis
[The formation of non-leukoid differentiated blood cells (NCI) ( NCI )] (UMLS (NCI) C0525006) =Organ or Tissue Function ;
26. Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells
(UMLS (NCI) C1334845) Myeloblasts 5-9% of Bone Marrow Nucleated Cells;
=Laboratory or Test Result
53. Myelosan
(UMLS (NCI) C0728926) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
27. Myeloblasts Under 1 Percent of Peripheral Blood White Cells
(UMLS (NCI) C1334847) Myeloblasts Under 1% of Peripheral Blood White Cells;
=Laboratory or Test Result
54. myelosuppression
[A condition in which bone marrow activity is decreased, resulting in fewer red blood cells, white blood cells, and platelets. Myelosuppression is a side effect of some cancer treatments. ( NCI )] (UMLS (NCI) C0854467) =Disease or Syndrome

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM